Association of Serum Magnesium Levels and Dyslipidemia in Patients of Type 2 Diabetes Mellitus
DOI:
https://doi.org/10.37506/es8yhb41Keywords:
yslipidemia, Magnesium, Type 2 Diabetes Mellitus.Abstract
BACKGROUND:Type 2 Diabetes Mellitus (T2DM) is characterized by hyperglycemia resulting from resistance to insulin and decreased insulin secretion by the beta cells of the pancreas. Intracellular magnesium is required as co-factor for many enzymes involved in lipid metabolism. Magnesium deficiency has been found to have a role in the disruption of lipid metabolism in patients of type 2 diabetes mellitus.
MATERIALS AND METHODS:This hospital based observational cross-sectional study was done between July 2021 and June,2022. 160 cases of Type 2 DM attending the Department ofMedicine, Assam Medical College & Hospital, Dibrugarh were enrolled for the study, as per inclusion and exclusion criteria.
RESULTS: Mean age was 52.59±7.13 years. Mean HbA1c was 10.02 ±1.83 %. Mean serum magnesium level was 1.54±0.42 mg/dl. Mean serum triglyceride was 267.27±89.13 mg/dl, mean total cholesterol was 271.65±65.18 mg/dl, mean LDLc was 143.31±15.07 mg/dl and mean HDLc was 39.86±10.55 mg/dl. There was a statistically significant negative correlation between serum magnesium and LDLc (r= -0.906), serum magnesium and Triglycerides, (r= -0.995) and serum magnesium and Cholesterol levels (r=-0.991) and a statistically significant positive correlation between serum magnesium and HDLc r=+0.596).
CONCLUSION: Low serum magnesium levels in diabetics correlate with dyslipidemia in Type 2 DM patients. Further studies are required to clinically investigate the role of magnesium in helping prevent dyslipidemia and complications among Type 2 DM patients.
References
Powers AC, Niswender KD, Evans-Molina C.Diabetes Mellitus: Diagnosis, Classification, Pathophysiology. In: Jameson JL, Fauci AS, Kasper DL,Hauser SL, Longo DL,Loscalzo J, editors. Harrison’s Principles of Internal Medicine. 21st ed. McGraw Hill; 2022. p. 3094-103.
Bringhurst FR, Kronenberg HM, Liu ES. Disorders of Bone Mineral Metabolism. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine. 21st editi. McGraw Hill; 2021. p. 3157–69.
Barbagallo M. Magnesium and type 2 diabetes. World J Diabetes.2015;6(10):1152.
Gommers L, Hoenderop JGJ, Bindels RJM, De Baaij JHF. Hypomagnesemia in Type 2 Diabetes: A Vicious Circle? Diabetes. 2016;65(1):3–13.
Haffner SM. Dyslipidemia Management in Adults With Diabetes. Diabetes Care. 2004;27(1):68–71.
Sajjan N, Shamsuddin M. A study of serum magnesium and dyslipidemia in type 2 diabetes mellitus patients. Int J Clin Biochem Res. 2016;3(1):36.
Rekha N, Bharath, Channakeshava S. Study of Prevalence of Hypomagnesemia in Patients with Type II Diabetes Mellitus. J Med Sci. 2017 Jun;3:55–8.
Hussain KSA. Serum lipid profile and serum magnesium levels in newly diagnosed type 2 diabetic subjects and normal individuals: a case control study. Int J Adv Med.2018;5(4).
Wahid A, Verma GC, Meena CP, Pathan AR. Study of serum magnesium level in patients with type 2 diabetes mellitus and it’s correlation with glycosylated hemoglobin and diabetic complications. Int J Adv Med. 2017;4:311–6.
Kumar P, Bhargava S, Agarwal P, Garg A, Khosla A. Association of serum magnesium with type 2 diabetes mellitus and diabetic retinopathy. J Fam Med Prim Care.2019;8(5):1671–7.
Lal J, Vasudev K, Kela A, Jain S. Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus. J Assoc Physicians India.2003;51:37–412.
Yossef HM, Ghanem NS, Al-Jarhi UM, Shaker OG. Relation of serum magnesium level to microvascular complications and the components of metabolic syndrome in patients with type 2 diabetes mellitus. Egypt J Intern Med. 2017 Sep;29(3):100–4.
Agrawal P, Arora S, Singh B, Manamalli A, Dolia PB. Association of macrovascular complications of type 2 diabetes mellitus with serum magnesium levels. Diabetes Metab Syndr Clin Res Rev.2011;5(1):41–4.
Ozder A.Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: A cross-sectional study. Lipids Health Dis. 2004 Dec 6;13:183.
Mishra S, Padmanaban P, Deepti GN, Sarkar G, Sumathi S, Toora BD. Serum Magnesium and Dyslipidemia in Type-2 Diabetes Mellitus. Biomed Res.2012;23(2):295–300.
Bhowmik B, Siddiquee T, Mujumder A, Afsana F, Ahmed T, Mdala IA, et al. Serum Lipid Profile and Its Association with Diabetes and Prediabetes in a Rural Bangladeshi Population. Int J Environ Res Public Health.2018;15(9):E1944.
Daya R, Bayat Z, Raal FJ.Prevalence and pattern of dyslipidaemia in type 2 diabetes mellitus patients at a tertiary care hospital. J Endocrinol Metab Diabetes South Africa.2017;22(3):31–5.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en